Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $226.54 | 6 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $120.95 | 1 | $0 (2019) |
| Roche Diagnostics Corporation | $76.70 | 4 | $0 (2024) |
| ABBVIE INC. | $28.89 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47.66 | 2 | ABBVIE INC. ($28.89) |
| 2023 | $39.47 | 2 | Roche Diagnostics Corporation ($39.47) |
| 2021 | $18.46 | 1 | Roche Diagnostics Corporation ($18.46) |
| 2019 | $120.95 | 1 | AstraZeneca Pharmaceuticals LP ($120.95) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $28.89 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/22/2024 | Roche Diagnostics Corporation | BenchMark ULTRA (Device) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Tissue Diagnostics | ||||||
| 04/26/2023 | Roche Diagnostics Corporation | CINtec PLUS Cytology (Device) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Tissue Diagnostics | ||||||
| 02/07/2023 | Roche Diagnostics Corporation | — | Food and Beverage | In-kind items and services | $21.76 | General |
| 10/13/2021 | Roche Diagnostics Corporation | VENTANA ANTI-MLH1 (M1) Mouse Monoclonal Primary Antibody (Device) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Tissue Diagnostics | ||||||
| 05/02/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $120.95 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,843 | 3,152 | $744,340 | $93,836 |
| 2022 | 17 | 1,756 | 3,161 | $752,510 | $103,378 |
| 2021 | 15 | 1,963 | 3,165 | $740,230 | $102,121 |
| 2020 | 15 | 1,981 | 3,139 | $744,402 | $98,719 |
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 764 | 1,223 | $354,780 | $31,761 | 9.0% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 138 | 246 | $93,480 | $14,877 | 15.9% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 326 | 407 | $69,190 | $10,538 | 15.2% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 111 | 363 | $36,300 | $7,747 | 21.3% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 57 | 215 | $45,150 | $6,392 | 14.2% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2023 | 30 | 86 | $21,500 | $4,035 | 18.8% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2023 | 30 | 56 | $15,120 | $2,870 | 19.0% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2023 | 25 | 26 | $12,220 | $2,795 | 22.9% |
| 88360 | Microscopic genetic analysis of tumor, manual | Office | 2023 | 21 | 75 | $15,750 | $2,372 | 15.1% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2023 | 65 | 86 | $18,920 | $1,796 | 9.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 53 | 62 | $17,980 | $1,721 | 9.6% |
| 88333 | Pathology cytologic examination of specimen during surgery, initial site | Facility | 2023 | 25 | 35 | $8,400 | $1,498 | 17.8% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Office | 2023 | 20 | 23 | $6,210 | $1,113 | 17.9% |
| 88172 | Evaluation of fine needle aspirate | Facility | 2023 | 13 | 34 | $4,080 | $913.44 | 22.4% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2023 | 23 | 40 | $3,600 | $804.14 | 22.3% |
| 88334 | Pathology cytologic examination of specimen during surgery, each additional site | Facility | 2023 | 11 | 29 | $4,060 | $710.86 | 17.5% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 18 | 20 | $3,400 | $501.22 | 14.7% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2023 | 39 | 40 | $7,600 | $342.80 | 4.5% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 28 | 32 | $1,600 | $299.24 | 18.7% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 21 | 29 | $1,740 | $263.96 | 15.2% |
| 85060 | Blood smear interpretation by physician with written report | Facility | 2023 | 14 | 14 | $840.00 | $256.48 | 30.5% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Office | 2023 | 11 | 11 | $2,420 | $229.68 | 9.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 695 | 1,171 | $339,700 | $33,224 | 9.8% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 150 | 290 | $110,200 | $18,351 | 16.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 354 | 471 | $80,070 | $12,574 | 15.7% |
About Dr. William Davis, M.D
Dr. William Davis, M.D is a Anatomic Pathology & Clinical Pathology healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578504007.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Davis, M.D has received a total of $226.54 in payments from pharmaceutical and medical device companies, with $47.66 received in 2024. These payments were reported across 6 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($226.54).
As a Medicare-enrolled provider, Davis has provided services to 7,543 Medicare beneficiaries, totaling 12,617 services with total Medicare billing of $398,055. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Location Tyler, TX
- Active Since 06/08/2006
- Last Updated 10/31/2014
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- NPI Number 1578504007
Products in Payments
- LYNPARZA (Drug) $120.95
- DALVANCE (Drug) $28.89
- BenchMark ULTRA (Device) $18.77
- VENTANA ANTI-MLH1 (M1) Mouse Monoclonal Primary Antibody (Device) $18.46
- CINtec PLUS Cytology (Device) $17.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology & Clinical Pathology Doctors in Tyler
Dr. Scott Lloyd, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $301,987
Ghousia Rizvi, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $323.25
Christopher Nguyen, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $165.24
Dr. Steven Sanchez, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $75.43
Dr. Brent Harris, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $70.34
Foy Forehand, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $69.53